Undeterred by Novo Nordisk failure, scientists consider GLP-1s as Alzheimer's prevention

Novo Nordisk's highly anticipated but ultimately unsuccessful Alzheimer's trials were a long shot for the maker of blockbuster drugs Ozempic and Wegovy, but scientists are still asking if GLP-1 drugs ... ...